Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPP30 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANKRD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTR7P1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HTR7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPP1R3C - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNKS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BTAF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIF20B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CPEB3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MARCH5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFIT5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFIT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFIT3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFIT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IDE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LIPA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on